News & Resources

Filters

Reset

Results

August 2023 Newsletter

August 24, 2023 Newsletter

ToxTracker is a unique, stem-cell based assay which takes advantage of a Green Fluorescent Protein (GFP) reporter system to identify…

IIVS Acquires Licenses to Work with DEA Schedule I Materials

July 29, 2023 IIVS News

IIVS is pleased to announce that our lab has acquired the necessary State and Federal licenses required to work with…

Multiscale Stiffness of Human Emphysematous Precision-Cut Lung Slices

May 22, 2023 Publication

IIVS is excited to announce a new publication in Science with co-authors at Boston University and Mechanobiologix (Newton, MA, USA)!…

IIVS Posters – SOT 2023 Annual Meeting

March 31, 2023 Poster/Presentation

IIVS presented several posters at SOT 2023. This post includes links to the full PDF versions of each poster presented.

62nd Annual Meeting of the Society of Toxicology

March 14, 2023 Newsletter

IIVS is looking forward to exhibiting at the 62nd Annual Meeting of the Society of Toxicology! If attending, please visit…

IIVS and Toxys Enter Into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation

March 9, 2023 IIVS News

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer…

March 2023 Newsletter

March 1, 2023 Newsletter

IIVS is pleased to share that the PMI In Vitro Alternatives Laboratory in Neuchâtel, Switzerland is now GIVIMP certified. Good…

Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters

February 23, 2023 Publication

The Institute for In Vitro Sciences (IIVS) is sponsoring a series of workshops to identify, discuss and develop recommendations for…

Derivation of a Point of Departure from In Vitro Methods for use in Skin Sensitization Risk Assessment Pt 2

February 16, 2023 Webinar

This webinar explores the use of Non-Animal Methodologies to derive a Point of Departure (predicted LLNA EC3) which can be…

Derivation of a Point of Departure from In Vitro Methods for use in Skin Sensitization Risk Assessment Pt 1

February 7, 2023 Webinar

This webinar explores the use of Non-Animal Methodologies to derive a Point of Departure (predicted LLNA EC3) which can be…

IIVS Leadership Newsletter

February 3, 2023 Newsletter

Please join me in congratulating Amanda Ulrey and Kristie Sullivan on their new roles as they work with Hans Rabe,…